{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:08:03Z","timestamp":1784758083283,"version":"3.55.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,6]]},"DOI":"10.2967\/jnumed.124.269190","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T18:54:37Z","timestamp":1743706477000},"page":"916-921","source":"Crossref","is-referenced-by-count":2,"title":["<sup>212<\/sup>Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation"],"prefix":"10.2967","volume":"66","author":[{"given":"Satyendra Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Maria","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Meral","family":"Kunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt R.","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalen","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinda","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025060410151043000_66.6.916.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2025060410151043000_66.6.916.2","doi-asserted-by":"crossref","first-page":"1204872","DOI":"10.3389\/fchem.2023.1204872","article-title":"Effective therapy with bismuth-212 labeled macroaggregated albumin in orthotopic mouse breast tumor models","volume":"11","author":"Kauffman","year":"2023","journal-title":"Front Chem."},{"key":"2025060410151043000_66.6.916.3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.hoc.2024.05.006","article-title":"Targeted therapy innovations for melanoma","volume":"38","author":"Amarillo","year":"2024","journal-title":"Hematol Oncol Clin North Am."},{"key":"2025060410151043000_66.6.916.4","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3390\/cancers15102718","article-title":"Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment","volume":"15","author":"Ziogas","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2025060410151043000_66.6.916.5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/14712598.2016.1185412","article-title":"Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle","volume":"16","author":"Dekempeneer","year":"2016","journal-title":"Expert Opin Biol Ther."},{"key":"2025060410151043000_66.6.916.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266388"},{"key":"2025060410151043000_66.6.916.7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/ph16070985","article-title":"212Pb]Pb-eSOMA-01: a promising radioligand for targeted alpha therapy of neuroendocrine tumors","volume":"16","author":"Chapeau","year":"2023","journal-title":"Pharmaceuticals (Basel)."},{"key":"2025060410151043000_66.6.916.8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-023-02636-x","article-title":"CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment","volume":"42","author":"Li","year":"2023","journal-title":"J Exp Clin Cancer Res."},{"key":"2025060410151043000_66.6.916.9","doi-asserted-by":"crossref","first-page":"1322773","DOI":"10.3389\/fchem.2023.1322773","article-title":"Pb-214\/Bi-214-TCMC-trastuzumab inhibited growth of ovarian cancer in preclinical mouse models","volume":"11","author":"Metebi","year":"2023","journal-title":"Front Chem."},{"key":"2025060410151043000_66.6.916.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0619"},{"key":"2025060410151043000_66.6.916.11","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/molecules24234314","article-title":"Development of targeted alpha particle therapy for solid tumors","volume":"24","author":"Tafreshi","year":"2019","journal-title":"Molecules."},{"key":"2025060410151043000_66.6.916.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2010.01.002"},{"key":"2025060410151043000_66.6.916.13","first-page":"153","article-title":"Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer","volume":"6","author":"Anbari","year":"2023","journal-title":"J Interv Med."},{"key":"2025060410151043000_66.6.916.14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0035-1564704","article-title":"Yttrium-90 radioembolization of hepatocellular carcinoma: performance, technical advances, and future concepts","volume":"32","author":"Molvar","year":"2015","journal-title":"Semin Intervent Radiol."},{"key":"2025060410151043000_66.6.916.15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm8010055","article-title":"History and evolution of yttrium-90 radioembolization for hepatocellular carcinoma","volume":"8","author":"Saini","year":"2019","journal-title":"J Clin Med."},{"key":"2025060410151043000_66.6.916.16","doi-asserted-by":"crossref","first-page":"116663","DOI":"10.1016\/j.biopha.2024.116663","article-title":"H2AX: a key player in DNA damage response and a promising target for cancer therapy","volume":"175","author":"Prabhu","year":"2024","journal-title":"Biomed Pharmacother."},{"key":"2025060410151043000_66.6.916.17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/cancers13040795","article-title":"Clinical candidates targeting the ATR-CHK1-WEE1 axis in cancer","volume":"13","author":"Gorecki","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2025060410151043000_66.6.916.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01178-6"},{"key":"2025060410151043000_66.6.916.19","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.3390\/ijms242216498","article-title":"Composition of conditioned media from radioresistant and chemoresistant cancer cells reveals miRNA and other secretory factors implicated in the development of resistance","volume":"24","author":"Molodtsova","year":"2023","journal-title":"Int J Mol Sci."},{"key":"2025060410151043000_66.6.916.20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-018-0626-6","article-title":"HMGB1 released by irradiated tumor cells promotes living tumor cell proliferation via paracrine effect","volume":"9","author":"He","year":"2018","journal-title":"Cell Death Dis."},{"key":"2025060410151043000_66.6.916.21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186602"},{"key":"2025060410151043000_66.6.916.22","doi-asserted-by":"crossref","first-page":"101543","DOI":"10.1016\/j.tranon.2022.101543","article-title":"Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines","volume":"26","author":"Abramenkovs","year":"2022","journal-title":"Transl Oncol."},{"key":"2025060410151043000_66.6.916.23","doi-asserted-by":"crossref","first-page":"18489","DOI":"10.1038\/s41598-019-54884-7","article-title":"Radiobiological effects of the alpha emitter Ra-223 on tumor cells","volume":"9","author":"Bannik","year":"2019","journal-title":"Sci Rep."},{"key":"2025060410151043000_66.6.916.24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cca.2019.10.003","article-title":"Circulating biomarkers of cell death","volume":"500","author":"Wimmer","year":"2020","journal-title":"Clin Chim Acta."},{"key":"2025060410151043000_66.6.916.25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15618"},{"key":"2025060410151043000_66.6.916.26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01801-2"},{"key":"2025060410151043000_66.6.916.27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cancers11060862","article-title":"Cancer stem cells and radioresistance: DNA repair and beyond","volume":"11","author":"Schulz","year":"2019","journal-title":"Cancers (Basel)."},{"key":"2025060410151043000_66.6.916.28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-021-01962-2","article-title":"Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation","volume":"40","author":"Goedegebuure","year":"2021","journal-title":"J Exp Clin Cancer Res."},{"key":"2025060410151043000_66.6.916.29","doi-asserted-by":"crossref","first-page":"775238","DOI":"10.3389\/fonc.2022.775238","article-title":"Targeting epithelial-to-mesenchymal transition in radioresistance: crosslinked mechanisms and strategies","volume":"12","author":"Qiao","year":"2022","journal-title":"Front Oncol."},{"key":"2025060410151043000_66.6.916.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102961"},{"key":"2025060410151043000_66.6.916.31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.trecan.2020.01.018","article-title":"Dark side of cytotoxic therapy: chemoradiation-induced cell death and tumor repopulation","volume":"6","author":"Jiang","year":"2020","journal-title":"Trends Cancer."},{"key":"2025060410151043000_66.6.916.32","first-page":"442","article-title":"Molecular mechanisms involved in tumor repopulation after radiotherapy","volume":"2","author":"Ng","year":"2013","journal-title":"Transl Cancer Res."},{"key":"2025060410151043000_66.6.916.33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3892\/ol.2014.1990","article-title":"Repopulation of tumor cells during fractionated radiotherapy and detection methods [review]","volume":"7","author":"Yang","year":"2014","journal-title":"Oncol Lett."},{"key":"2025060410151043000_66.6.916.34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2023.12.049","article-title":"Establishing updated safety standards for independent 99mTc-MAA SPECT\/CT treatment planning in radioembolization","volume":"119","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025060410151043000_66.6.916.35","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1038\/s41598-021-82887-w","article-title":"Diagnostic and prognostic value of 99mTc-MAA SPECT\/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image","volume":"11","author":"Son","year":"2021","journal-title":"Sci Rep."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.269190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:16:48Z","timestamp":1749057408000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.269190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,2]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.2967\/jnumed.124.269190"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.269190","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}